Search research articles
Contact Us
Filters
Showing results (51-60 of 105) with videos related to
Page
of 11
Sort By:
Neurobiology of Disease
|
August 9, 2005
Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS
Jerònia Lladó, Christine Haenggeli, Andrea Pardo, et al.
Muscle & Nerve
|
March 19, 2025
Akt Activation With IPL344 Treatment for Amyotrophic Lateral Sclerosis: First in Human, Open-Label Study
Marc Gotkine, David A Schoenfeld, Ilana Cohen, et al.
Muscle & Nerve
|
November 25, 2010
Characterizing spinal muscular atrophy with electrical impedance myography
Seward B Rutkove, Jeremy M Shefner, Matt Gregas, et al.
Journal of Neuromuscular Diseases
|
May 5, 2025
Application of the ENCALS predictive survival model in assessing the effect of the 24/44 inclusion criteria in FORTITUDE-ALS
Tyrell Simkins Lead, Jeremy M Shefner, Stuart Kupfer, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 27, 2025
Participant, site personnel and sponsor perspectives on decentralized trial features in COURAGE-ALS: a randomized clinical trial
Stacy A Rudnicki, Paulos Gebrehiwet, Stuart Kupfer, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 29, 2018
Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system
Jeremy M Shefner, Seward B Rutkove, James B Caress, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
April 26, 2021
Putting the patient first: The validity and value of surface-based electrical impedance myography techniques
Seward B Rutkove, Pushpa Narayanaswami, W David Arnold, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 7, 2018
VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics
Jinsy A Andrews, Merit E Cudkowicz, Orla Hardiman, et al.
JAMA Neurology
|
November 29, 2017
Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis
Jinsy A Andrews, Lisa Meng, Sarah F Kulke, et al.
Annals of Clinical and Translational Neurology
|
September 11, 2020
Efficacy of Ciprofloxacin/Celecoxib combination in zebrafish models of amyotrophic lateral sclerosis
Hagit Goldshtein, Alexandre Muhire, Virginie Petel Légaré, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 105) with videos related to
Sort By:
Page
of 11
Neurobiology of Disease
|
August 9, 2005
Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS
Jerònia Lladó, Christine Haenggeli, Andrea Pardo, et al.
Muscle & Nerve
|
March 19, 2025
Akt Activation With IPL344 Treatment for Amyotrophic Lateral Sclerosis: First in Human, Open-Label Study
Marc Gotkine, David A Schoenfeld, Ilana Cohen, et al.
Muscle & Nerve
|
November 25, 2010
Characterizing spinal muscular atrophy with electrical impedance myography
Seward B Rutkove, Jeremy M Shefner, Matt Gregas, et al.
Journal of Neuromuscular Diseases
|
May 5, 2025
Application of the ENCALS predictive survival model in assessing the effect of the 24/44 inclusion criteria in FORTITUDE-ALS
Tyrell Simkins Lead, Jeremy M Shefner, Stuart Kupfer, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 27, 2025
Participant, site personnel and sponsor perspectives on decentralized trial features in COURAGE-ALS: a randomized clinical trial
Stacy A Rudnicki, Paulos Gebrehiwet, Stuart Kupfer, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
September 29, 2018
Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system
Jeremy M Shefner, Seward B Rutkove, James B Caress, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
April 26, 2021
Putting the patient first: The validity and value of surface-based electrical impedance myography techniques
Seward B Rutkove, Pushpa Narayanaswami, W David Arnold, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 7, 2018
VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics
Jinsy A Andrews, Merit E Cudkowicz, Orla Hardiman, et al.
JAMA Neurology
|
November 29, 2017
Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis
Jinsy A Andrews, Lisa Meng, Sarah F Kulke, et al.
Annals of Clinical and Translational Neurology
|
September 11, 2020
Efficacy of Ciprofloxacin/Celecoxib combination in zebrafish models of amyotrophic lateral sclerosis
Hagit Goldshtein, Alexandre Muhire, Virginie Petel Légaré, et al.
Page
of 11